Inside The Recent Surge In Cancer Biotech IPOs
ProNAI Therapeutics Inc. raked in $138 million in an initial public offering that hit sweetened terms Wednesday, marking the latest cancer-focused life science company to draw strong demand as the success...To view the full article, register now.
Already a subscriber? Click here to view full article